LivaNova PLC (LIVN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.03B
Last updated: Nov 17, 2026 at 4:20 PM ET
LivaNova PLC (LIVN) Statistics
LivaNova (LIVN) has a market cap of $5.03B and an enterprise value of $4.77B. Its share count is up 3.99% from a year earlier. Its return on invested capital of 9.74% compares with a 4.94% median across 8 similar companies.
Total Valuation
Enterprise value is 5.26% below the market cap, as cash exceeds debt.
| Market Cap | $5.03B |
|---|---|
| Enterprise Value | $4.77B |
| Latest price (Nov 17, 2026) | $91.92 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.5x and 3.8x. Its year-end P/E ranged from 13.7x to 52.1x from 2016 to 2025.
| P/E Ratio | 23.6x |
|---|---|
| Forward P/E | 20.3x |
| P/S Ratio | 3.5x |
| Forward P/S | 3.3x |
| P/B Ratio | 3.8x |
| P/TBV Ratio | 13.8x |
| P/FCF Ratio | 40.9x |
| P/OCF Ratio | 21.2x |
| PEG Ratio | 1.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 23.7x EBITDA and 38.9x free cash flow.
| EV / Earnings | 24.3x |
|---|---|
| EV / Sales | 3.2x |
| EV / EBITDA | 23.7x |
| EV / EBIT | 29.3x |
| EV / FCF | 38.9x |
Price Statistics
The stock is up 66.04% over 52 weeks and trades 13.82% above its 50-day average.
| Beta (1Y) | 1.03 |
|---|---|
| 52-Week Change | +66.04% |
| 1-Month Change | +17.64% |
| 3-Month Change | +13.71% |
| 6-Month Change | +26.06% |
| 5-Year Change | +2.93% |
| 10-Year Change | +39.33% |
| Total Return (1Y) | +66.04% |
| Total Return (3Y CAGR) | +25.25% |
| Total Return (5Y CAGR) | +1.80% |
| Return vs SPY (1Y) | +59.01% |
| Max Drawdown (1Y) | -18.89% |
| Max Drawdown (3Y) | -47.23% |
| Sharpe Ratio (1Y) | 1.42 |
| Correlation with SPY (1Y) | 0.37 |
| 50-Day Average | $80.76 |
| 200-Day Average | $74.44 |
| 52-Week Range | $53.37 to $99.38 |
| RSI (14 Days) | 65.6 |
| Average Volume (20 Days) | 782.87K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.46x current liabilities, and total debt is 0.22x shareholder equity.
| Current Ratio | 1.46x |
|---|---|
| Quick Ratio | 1.22x |
| Debt / Equity | 0.22x |
| Debt / EBITDA | 1.42x |
| Debt / FCF | 2.32x |
| Interest Coverage | 3.76x |
Returns and Efficiency
Return on invested capital is 9.74% over the last 12 months, against a 5-year average of -2.36%.
| Return on Equity (ROE) | 14.29% |
|---|---|
| Return on Assets (ROA) | 7.23% |
| Return on Invested Capital (ROIC) | 9.74% |
| Return on Capital Employed (ROCE) | 8.25% |
| ROE (5Y Average) | -6.34% |
| ROA (5Y Average) | -3.20% |
| ROIC (5Y Average) | -2.36% |
| Asset Turnover | 0.57x |
| Inventory Turnover | 2.76x |
| Receivables Turnover | 5.41x |
| Cash Conversion Cycle | 120 days |
Scores
LIVN has an Altman Z-Score of 2.76, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.76 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.51B over the last 12 months is up 11.70% from the 12 months before.
| Revenue | $1.51B |
|---|---|
| Revenue Growth (YoY) | +11.70% |
| Gross Profit | $1.02B |
| Operating Income | $172.70M |
| Pretax Income | $119.59M |
| Net Income | $196.08M |
| EBITDA | $211.36M |
| EBIT | $162.79M |
| Reported EPS (TTM) | $3.89 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 50.55% of the $2.71B in total assets.
| Cash and Equivalents | $563.50M |
|---|---|
| Total Debt | $299.09M |
| Net Cash | $264.41M |
| Net Cash Per Share | $4.61 |
| Working Capital | $342.60M |
| Shareholder Equity | $1.37B |
| Book Value Per Share | $23.90 |
| Tangible Book Value | $382.60M |
| Tangible Book Per Share | $6.67 |
| Total Assets | $2.71B |
| Total Liabilities | $1.34B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $108.84M of capital spending, operating cash flow left $128.96M of free cash flow.
| Operating Cash Flow | $237.80M |
|---|---|
| Capital Expenditures | $108.84M |
| Free Cash Flow | $128.96M |
| FCF Per Share | $2.34 |
| Depreciation and Amortization | $64.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 11.46%, against a 5-year average of 2.23%.
| Gross Margin | 67.91% |
|---|---|
| Operating Margin | 11.46% |
| Pretax Margin | 7.94% |
| Net Margin | 13.01% |
| EBITDA Margin | 14.03% |
| EBIT Margin | 10.80% |
| FCF Margin | 8.56% |
| Gross Margin (5Y Average) | 68.29% |
| Operating Margin (5Y Average) | 2.23% |
| Net Margin (5Y Average) | -6.49% |
Growth
Revenue grew 10.75% a year over 3 years, and EPS 16.14% a year.
| Revenue Growth (3Y CAGR) | +10.75% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.24% |
| EPS Growth (3Y CAGR) | +16.14% |
| EPS Growth (5Y CAGR) | +24.24% |
| FCF Growth (3Y CAGR) | +58.62% |
| Book Value Per Share Growth (2Y CAGR) | -3.26% |
| Tangible Book Per Share Growth (2Y CAGR) | -13.05% |
Dividends and Yields
LIVN does not pay a dividend. Its free cash flow yield is 2.44%.
| Earnings Yield | 4.24% |
|---|---|
| FCF Yield | 2.44% |
| Shareholder Yield | 0.14% |
Peer Position
Against 9 similar companies, LIVN has the 6th highest P/E.
P/E RatioPeer median 23.8x
P/S RatioPeer median 3.5x
ROICPeer median 4.94%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.73%
| P/E Ratio | 23.6x vs 23.8x median |
|---|---|
| P/S Ratio | 3.5x vs 3.5x median |
| ROIC | 9.74% vs 4.94% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +11.70% vs +8.73% median |
Analyst Forecast
Consensus estimates put revenue growth at 8.67% and EPS growth at 12.16% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.67% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.16% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LIVN
What is LIVN's market cap?
LivaNova has a market cap of $5.03B. Its enterprise value, which adds debt and subtracts cash, is $4.77B.
What is LIVN's P/E ratio?
LivaNova has a trailing P/E ratio of 23.6x and a forward P/E of 20.3x.
How many shares of LIVN are outstanding?
LivaNova has 57.40M shares outstanding. The count is up 3.99% from a year earlier.
Does LIVN pay a dividend?
No. LivaNova does not pay a dividend.
How much debt does LIVN have?
LivaNova has $299.09M of total debt and $563.50M of cash and equivalents, a net cash position of $264.41M.
LIVN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts